Cargando…
Common genetic variants do not predict recurrent events in coronary heart disease patients
BACKGROUND: It is unclear whether genetic variants identified from single nucleotide polymorphisms (SNPs) strongly associated with coronary heart disease (CHD) in genome-wide association studies (GWAS), or a genetic risk score (GRS) derived from them, can help stratify risk of recurrent events in pa...
Autores principales: | Thompson, P. L., Hui, J., Beilby, J., Palmer, L. J., Watts, G. F., West, M. J., Kirby, A., Marschner, S., Simes, R. J., Sullivan, D. R., White, H. D., Stewart, R., Tonkin, A. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908687/ https://www.ncbi.nlm.nih.gov/pubmed/35264114 http://dx.doi.org/10.1186/s12872-022-02520-0 |
Ejemplares similares
-
Semi-parametric risk prediction models for recurrent cardiovascular events in the LIPID study
por: Cui, Jisheng, et al.
Publicado: (2010) -
Circulating Cystatin C Is an Independent Risk Marker for Cardiovascular Outcomes, Development of Renal Impairment, and Long‐Term Mortality in Patients With Stable Coronary Heart Disease: The LIPID Study
por: West, Malcolm, et al.
Publicado: (2022) -
B‐Type Natriuretic Peptide and Long‐Term Cardiovascular Mortality in Patients With Coronary Heart Disease
por: Stewart, Ralph A. H., et al.
Publicado: (2022) -
Changes in Lipoprotein‐Associated Phospholipase A2 Activity Predict Coronary Events and Partly Account for the Treatment Effect of Pravastatin: Results From the Long‐term Intervention with Pravastatin in Ischemic Disease Study
por: White, Harvey D., et al.
Publicado: (2013) -
Which lipid measurement should we monitor? An analysis of the LIPID study
por: Glasziou, Paul P, et al.
Publicado: (2014)